[1]
“Comparison Of The Clinical Presentation, Antimicrobial Properties, And Outcomes Of Lung And Disseminated Nocardiosis Patients”, Journal of Pharmaceutical Negative Results, pp. 606–613, Jan. 2023, doi: 10.47750/pnr.2023.14.02.75.